196 related articles for article (PubMed ID: 34311438)
1. Episomal vector reprogramming of human umbilical cord blood natural killer cells to an induced pluripotent stem cell line MUSIi013-A.
Klaihmon P; Luanpitpong S; Lorthongpanich C; Laowtammathron C; Waeteekul S; Terbto P; Issaragrisil S
Stem Cell Res; 2021 Aug; 55():102472. PubMed ID: 34311438
[TBL] [Abstract][Full Text] [Related]
2. Establishment of human induced pluripotent stem cell line MUi028-A from normal fetal skin fibroblasts.
Chumchuen S; Satirapod C; Tangprasittipap A; Hongeng S
Stem Cell Res; 2022 Apr; 60():102675. PubMed ID: 35114587
[TBL] [Abstract][Full Text] [Related]
3. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
4. Derivation of a MUSIi012-A iPSCs from mobilized peripheral blood stem cells.
Laowtammathron C; Srisook P; Chingsuwanrote P; Jiamvoraphong N; Waeteekul S; Terbto P; U-Pratya Y; Lorthongpanich C; Issaragrisil S
Stem Cell Res; 2019 Dec; 41():101597. PubMed ID: 31669974
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of human iPSC line NCCSi004-A from umbilical cord blood (UCB) derived CD34
Fernandes S; Tembe S; Singh S; Vardhan S; Nair V; Kale V; Limaye L
Stem Cell Res; 2019 Mar; 35():101392. PubMed ID: 30711803
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterization of human iPSC line from CD34
Fernandes S; Talwadekar M; Agarwal R; Nair V; Kale V; Limaye L
Stem Cell Res; 2017 Jan; 18():60-63. PubMed ID: 28395807
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of induced pluripotent stem cell line IITGi001-A derived from adult human primary dermal fibroblasts.
Raina K; Joshi G; Modak K; Premkumar C; Priyanka S; Rajesh P; Velayudhan SR; Thummer RP
Stem Cell Res; 2023 Sep; 71():103159. PubMed ID: 37392703
[TBL] [Abstract][Full Text] [Related]
8. Establishment of PLAFMCi004-A induced pluripotent stem cells derived from PBMCs from a healthy individual.
Shang S; Chen K; Cai G; Bai X; Chen X; Li Q
Stem Cell Res; 2021 May; 53():102316. PubMed ID: 33878710
[TBL] [Abstract][Full Text] [Related]
9. Derivation of an induced pluripotent stem cell line (MUSIi004-A) from dermal fibroblasts of a 48-year-old spinocerebellar ataxia type 3 patient.
Ritthaphai A; Wattanapanitch M; Pithukpakorn M; Heepchantree W; Soi-Ampornkul R; Mahaisavariya P; Triwongwaranat D; Pattanapanyasat K; Vatanashevanopakorn C
Stem Cell Res; 2018 Jul; 30():113-116. PubMed ID: 29852467
[TBL] [Abstract][Full Text] [Related]
10. Derivation of human iPSC line NCCSi002-A from umbilical cord blood (UCB) CD34+cells of donor from Indian ethnicity.
Fernandes S; Shinde P; Khan N; Singh S; Vardhan S; Nair V; Kale V; Limaye L
Stem Cell Res; 2018 Jan; 26():80-83. PubMed ID: 29268156
[TBL] [Abstract][Full Text] [Related]
11. Generation of induced pluripotent stem cells from peripheral blood CD34+ hematopoietic progenitors of a 31year old healthy woman.
Tangprasittipap A; Jittorntrum B; Wongkummool W; Kitiyanant N; Tubsuwan A
Stem Cell Res; 2017 Apr; 20():91-93. PubMed ID: 28395748
[TBL] [Abstract][Full Text] [Related]
12. Generation of integration-free human induced pluripotent stem cells from a patient with sporadic Parkinson's disease.
Lee Y; Jeong D; Ham S; Son J; Ko K
Stem Cell Res; 2024 Jun; 77():103416. PubMed ID: 38615589
[TBL] [Abstract][Full Text] [Related]
13. Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS).
Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
Stem Cell Res; 2017 Dec; 25():291-295. PubMed ID: 29150092
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an induced pluripotent stem cell line (ZZUSAHi002-A) derived from peripheral blood mononuclear cells of a healthy individual.
Liu S; Niu S; Li Y; Xiong H; Li Y; Jian L; Zhang L
Stem Cell Res; 2020 Oct; 48():101966. PubMed ID: 32911326
[TBL] [Abstract][Full Text] [Related]
15. Preferential Hematopoietic Differentiation in Induced Pluripotent Stem Cells Derived From Human Umbilical Cord Arterial Endothelial Cells.
Pei H; Li H; Xu L; Zhang B; Zhang H; Jia Y; Liang L; Xie X; Fan Z; Yang Z; Wang X; Song F; He L; Yue W; Pei X
Arterioscler Thromb Vasc Biol; 2023 May; 43(5):697-712. PubMed ID: 36951064
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line carrying a deletion of exons 51-53 of the dystrophin gene (CCMi003-A).
Rovina D; Castiglioni E; Farini A; Bellichi M; Gervasini C; Paganini S; Di Segni M; Santoro R; Torrente Y; Pompilio G; Gowran A
Stem Cell Res; 2019 Oct; 40():101544. PubMed ID: 31465894
[TBL] [Abstract][Full Text] [Related]
17. Non-integrating episomal vectors induced pluripotent stem cell line (SDPHi001-A) from a healthy female individual.
Shao J; Shao C; Jin Y; Wang X; Fan H; Yang G
Stem Cell Res; 2021 Oct; 56():102540. PubMed ID: 34547706
[TBL] [Abstract][Full Text] [Related]
18. Episomal plasmid-based generation of an iPSC line from a 79-year-old individual carrying the APOE4/4 genotype: i11001.
Zulfiqar S; Fritz B; Nieweg K
Stem Cell Res; 2016 Nov; 17(3):544-546. PubMed ID: 27789405
[TBL] [Abstract][Full Text] [Related]
19. Generation of the human erythroblast-derived iPSC line UBTi001-A.
Avdili A; Rohrhofer L; Auer M; Bernecker C; Schlenke P; Dorn I
Stem Cell Res; 2022 Oct; 64():102910. PubMed ID: 36103773
[TBL] [Abstract][Full Text] [Related]
20. Episomal plasmid-based generation of an iPSC line from an 83-year-old individual carrying the APOE4/4 genotype: i10984.
Zulfiqar S; Fritz B; Nieweg K
Stem Cell Res; 2016 Nov; 17(3):523-525. PubMed ID: 27789402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]